ArticleThe Analyst2025
Functional regression for SERS spectrum transformation across diverse instruments.
Article in The Analyst, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Surface-enhanced Raman spectroscopy (SERS) holds remarkable potential for the rapid and portable detection of trace molecules. However, the analysis and comparison of SERS spectra are challenging due to the diverse range of instruments used for data acquisition. In this paper, a spectra instrument transformation framework based on the penalized functional regression model (SpectraFRM) is introduced for cross-instrument mapping with subsequent machine learning classification to compare transformed spectra with standard spectra. In particular, the nonparametric forms of the functional response, predictors, and coefficients employed in SepctraFRM allow for efficient modeling of the nonlinear relationship between target spectra and standard spectra. In the leave-one-out training and test of 20 analytes across four instruments, the results demonstrate that SpectraFRM can provide interpretable corrections to peaks and baseline spectra, leading to approximately 11% error reduction, compared with original spectra. With an additional feature extraction step, the transformed spectra outperform the original spectra by 10% in analytes identification tasks. Overall, the proposed method is shown to be flexible, robust, accurate, and interpretable despite varieties of analytes and instruments, making it a potentially powerful tool for the standardization of SERS spectra from various instruments.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.